产品详情
靶点信息
RIP1 (293T cells) | ||||
490 nM(EC50) |
In vitro (25°C) | DMSO | Warmed: 43 mg/mL (165.81 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 5% DMSO+45% PEG 300+ddH2O | 9 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 38.56 mL | 192.8 mL | 385.61 mL |
0.5 mM | 7.71 mL | 38.56 mL | 77.12 mL |
1 mM | 3.86 mL | 19.28 mL | 38.56 mL |
5 mM | 0.77 mL | 3.86 mL | 7.71 mL |
*The above data is based on the productmolecular weight 259.33. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A11973 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 259.33 |
Formula | C13H13N3OS |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 4311-88-0 |
SMILES | CN1C(=O)C(NC1=S)CC2=CNC3=CC=CC=C32 |
产品标签
Product Questions
Product Questions
Apremilast (CC 10004)
Apremilast (CC 10004)是一种新型的PDE4抑制剂,可抑制人类风湿性滑膜细胞自发产生肿瘤坏死因子-α,并改善实…
Pomalidomide (CC-4047)
Pomalidomide (CC-4047)是沙利度胺的衍生物,在PBMCs中IC50为13 nM,并起免疫调节剂的作用。
QNZ (EVP4593)
QNZ抑制转录因子NF-κB的激活,已被用于研究NF-κB信号传导。
Lenalidomide (CC-5013)
Lenalidomide (CC-5013)是Thalidomide的衍生物。在体外,Lenalidomide具有三种主要活性:直接抗肿瘤作用、抑制肿瘤细…
Thalidomide
Thalidomide可以在体内直接抑制bFGF或VEGF诱导的血管生成。